Key figures
- Annual revenue
- EGP 24.7M
- Net profit
- —
- Net margin
- —
- Revenue trend
- Growing revenue
FY 2025
Deal analysis
Sign in to see this deal rated in stars: the price against the profit, the return against bank certificates, what the seller left out, and questions to ask them.
About the business
A company working in the field of pharmaceuticals and nutritional supplements, founded in 2019 in Cairo, and it has 8 products on the market. It employs 26 people who cover about 30% of the country so far, which leaves wide room for expansion. Its 2025 revenue reached about 24.7 million Egyptian pounds.
Translated automatically from Arabic.
Deal details
- Legal form
- Sole proprietorship
- Founded
- 2019
- Registered capital
- EGP 500,000
- Team size
- 11–50 employees
- Premises
- Leased premises
- Lease remaining
- 7 years
- Deal type
- Sale of the whole company
- Deferred payments
- No
- Reason for selling
- Retirement
Listed 4 Nov 2026